Licensing Model

At Mingowood Pharmacal, we redefine industry standards through cutting-edge formulation technologies. Our commitment to innovation goes beyond product development; we're pioneers in offering licensing opportunities for our groundbreaking formulations. By partnering with us, your company gains access to transformative technology that elevates your products to new heights.

· Proven Excellence: Benefit from a formulation technology that has demonstrated unparalleled success in enhancing product stability and efficacy.

· Customization for Your Needs: Our technology is adaptable, ensuring seamless integration with your existing processes and products.

· Strategic Advantage: Stay ahead of the competition by incorporating our proprietary formulations, giving your products a distinctive edge in the market.

At Mingwood Pharmacal, we believe in collaborative success. Our monetization model revolves around licensing our formulation technology to like-minded companies seeking to enhance their product offerings. Here's how it works:

- Tailored Licensing Agreements: We work closely with your team to create licensing agreements that align with your business goals, ensuring a mutually beneficial partnership.

- Flexible Financial Arrangements: Choose from a range of financial structures, including upfront fees, royalties, or customized payment plans that suit your company's budget and preferences.

- Continuous Support: Beyond the licensing agreement, we provide scientific support to facilitate a smooth integration of our technology into your processes.  

· Innovation Leadership: Be at the forefront of your industry with first mover advantage by leveraging the innovation that defines Intercalyx™.

· Shared Success: We're invested in your success. Our licensing model is designed to create a win-win situation, fostering long-term, collaborative partnerships.

Ready to explore a licensing agreement? Our VP of Business Development is available to discuss how Mingowood’s patented platform fits your pipeline and business model.